CD8A and cancer: Although administration of V-9302 to decrease glutamine availability increases glucose uptake by cancer cells and immune cells in allograft models, the growth of tumors harboring tumor-infiltrating Tregs, CD8(+) T cells, and NK cells is suppressed128.